Register
TransPyloric shuttle intragastric device approved for obesity |
Clinical News
eMediNexus Coverage from: 
TransPyloric shuttle intragastric device approved for obesity
eMediNexus,  26 April 2019
remove_red_eye 631 Views
#Business And Medicine #Gastroenterology #Pharmacist #Public Health

0 Read Comments                

The US Food and Drug Administration (FDA) has approved the TransPyloric Shuttle (TPS) intragastric device to help eligible obese patients lose weight. The intragastric device is endoscopically implanted into the stomach to help patients feel full sooner and then endoscopically explanted after a year. It is made of silicone and is 85% to 90% smaller.

To comment on this article,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now